<DOC>
	<DOCNO>NCT01667718</DOCNO>
	<brief_summary>To examine compare efficacy 2 week Levofloxacin-containing therapy without Bismuth H.pylori treatment .</brief_summary>
	<brief_title>Bismuth Improves Efficacy Levofloxacin-containing Triple Therapy Helicobacter Pylori Treatment</brief_title>
	<detailed_description>The success rate standard triple therapy H. pylorus infection decrease recently.Fluoroquinolone propose replace clarithromycin alternative treatment . However prevalence H.pylori resistance Levofloxacin increase rapidly area . The purpose study observe efficacy 14 day Levofloxacin triple therapy-based , bismuth-containing quadruple therapy H.pylori treatment .</detailed_description>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Bismuth</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Potassium Citrate</mesh_term>
	<criteria>patient present upper gastrointestinal symptom endoscopically proven H.pyloripositive functional dyspepsia scar peptic ulcer patient peptic ulcer , previous H.pylori eradication therapy , previous gastric surgery , pregnancy , lactation , major systemic disease , receipt antisecretory therapy , antibiotic bismuth precede 4 week , allergy one medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>eradication</keyword>
	<keyword>helicobacter pylorus</keyword>
	<keyword>bismuth</keyword>
</DOC>